A panel of independent advisers to the Food and Drug Administration is meeting Wednesday to discuss the agency’s potential approval of MDMA-assisted therapy for post-traumatic stress disorder, marking a pivotal moment for the booming field of psychedelic medicine.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnA panel of independent advisers to the Food and Drug Administration is meeting Wednesday to discuss the agency’s potential approval of MDMA-assisted therapy for post-traumatic stress disorder, marking a pivotal moment for the booming field of psychedelic medicine.nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]